Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

24.25
Delayed Data
As of 11:20am ET
 +0.50 / +2.11%
Today’s Change
11.85
Today|||52-Week Range
24.35
+73.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-98.6M-83.3M-21.0M-88.1M
 
 
 
 
 
Depreciation8.7M8.7M9.1M9.2M
 
 
 
 
 
Total Other Cash Flow15.8M12.8M18.9M16.4M
 
 
 
 
 
Funds From Operations-74.1M-61.8M7.0M-62.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-9.0M9.7M-852.0K-32.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-65.2M-71.6M7.9M-30.4M
 
 
 
 
 
 
InvestingIncrease In Investments-111.8M-405.7M-360.0M-524.9M
 
 
 
 
 
Decrease In Investments195.3M245.9M445.7M420.7M
 
 
 
 
 
Capital Expenditures-8.4M-4.1M-5.6M-17.1M
 
 
 
 
 
Other Investing - Sources0.000.000.00267.0K
 
 
Net Cash Flow Investing75.2M-163.8M80.0M-121.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale21.6M237.5M2.4M74.3M
 
 
 
 
 
Common Preferred Redeemed0.00-2.0M-1.1M0.00
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing21.6M235.5M1.3M74.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash31.6M53.0K89.3M-77.1M